Top compounds associated with response to NUCB1


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.00055 1
mRNA MG-132 CTRPv2 pan-cancer AAC -0.001 1
mRNA GW843682X GDSC1000 pan-cancer AAC 0.00047 1
mRNA Platin CTRPv2 pan-cancer AAC 0.00022 1
mRNA Crizotinib gCSI pan-cancer AAC 0.00026 1
mRNA ML083 CTRPv2 pan-cancer AAC 4.5e-05 1
Download CSV